JPMorgan Chase Financing Receivables Individually Evaluated for Impairment decreased by 4.0% to $7.93B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.4%, from $6.70B to $7.93B. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates rising credit stress among specific large borrowers, while a decrease suggests successful resolution or reduction of troubled assets.
This metric measures the carrying amount of specific financing receivables that have been identified as impaired and are...
Standard disclosure for banks to provide transparency into their non-performing or impaired loan portfolios.
financing_receivable_impairment_individual| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.38B | $17.88B | $16.91B | $15.92B | $15.29B | $5.75B | $6.03B | $5.72B | $6.14B | $6.32B | $6.29B | $6.70B | $7.41B | $8.26B | $7.93B |
| QoQ Change | — | -7.7% | -5.4% | -5.9% | -3.9% | -62.4% | +4.8% | -5.0% | +7.3% | +2.8% | -0.4% | +6.4% | +10.7% | +11.4% | -4.0% |
| YoY Change | — | — | — | -17.9% | -14.4% | -66.0% | -62.1% | -62.6% | +6.9% | +4.8% | +10.0% | +9.0% | +17.4% | +31.3% | +18.4% |